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1. Introduction 
Glycosylation participates in many important biological processes including cell growth, 
migration, adhesion, differentiation, signal transduction and receptor activation (1). 
Notable among the emerging glycosylations, O-GlcNAcylation has garnered 
considerable interest during the last few decades (2). O-GlcNAcylation is the product of 
glucose influx through the hexosamine biosynthetic pathway (HBP), which integrates 
glucose, amino acid, fatty acid and nucleotide to serve as the donor substrate for O-
GlcNAcylation, uridine diphosphate GlcNAc (UDP-GlcNAc) (3). O-GlcNAcylation is 
controlled by O-GlcNAc transferase (OGT) and is a specific type of post-translational 
modification that consists of the covalent attachment of single GlcNAc to the nucleus and 
The synthesis of O-GlcNAcylation 
(Refered to Vasconcelos-Dos-Santos A. et al. Front Oncol, 2015, 00138.) 
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cytoplasm of the serine or threonine residue of an extremely large family of target proteins  
(4,5). This post-translational modification is essential for cell survival and division (6), 
and aberrant O-GlcNAcylation provokes tumorigenesis, diabetes, and Alzheimer’s 
disease (AD) by regulating cell signaling, transcription, metabolism, and cytoskeletal 
formation (7-10). The increased O-GlcNAcylation seems to be a general characteristic of 
cancer cells. For example, higher levels of O-GlcNAcylation expression have been 
observed in cancers of the liver (11), lung, colon (12), and breast (13). Furthermore, 
numerous breast cancer cell lines have shown higher levels of O-GlcNAcylation, and the 
levels of OGT expression in aggressive breast cancer cell lines are much higher than those 
seen in less aggressive breast cancer cell lines (14). O-GlcNAc modifications have also 
been observed in important target proteins such as p53(15), HIF-1α (16), β-catenin (13), 
and G6PD (17), which are involved in the regulation of malignant cancer characteristics 
by controlling cellular metabolism and proliferation. On the other hand, the suppression 
of OGT expression in breast or liver cancer cell lines decreases cell motility, which 
suggests that O-GlcNAcylation could be involved in cell migration (13,18).  
Cell migration is a highly integrated multistep process that includes the development of 
cytoplasmic protrusions, attachment and spreading (19). The migratory capacity of cancer 
cells is initially mediated by alterations in the expression of cell-surface molecules known 
as integrins (20). It is becoming increasingly clear that integrins are crucial for cell 
migration in the tumor microenvironment (21). Following ligand binding, integrins 
cluster into focal contacts that contain different focal adhesion (FA)-associated proteins 
such as α-actinin, vinculin, talin, focal adhesion kinase (FAK), and paxillin, which link 
the integrins to the actin cytoskeleton (22). The processes of adhesion formation and 
disassembly drive the migration cycle through ligand binding, which in turn regulates 
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integrin activity and cytoskeletal complex formation, as well as adhesion dynamics (23). 
O-GlcNAcylation appears to occur in actin cytoskeletal regulatory proteins such as 
paxillin (24) and talin (25), as well as in microtubule-assembly proteins such as tubulin 
(26) and in microtubule-associated proteins (27). However, whether and how O-
GlcNAcylation impacts cell migration remains unclear.  
 
Proposed molecular mechanism of FA complex regulated by O-GlcNAc 
In the present study, we used the doxycycline shRNA-inducible system to knockdown the 
OGT gene to identify the biological functions of O-GlcNAcylation and its regulatory 
mechanisms in cell adhesion and migration. We found that the knockdown of OGT 
aberrantly increased cell adhesion, FA formation, and integrin β1 activation, which in turn 
decreased cell migration. Thus, our findings may provide new insight into integrin-
mediated cell migration and explain why O-GlcNAcylation is usually highly expressed 
in some malignant cancers. 
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2. Materials and methods 
 
2.1 Antibodies and reagents 
Experiments were performed using the following antibodies: mAb against O-GlcNAc 
(CTD110.6, 9875S) and peroxidase-conjugated secondary antibody against rabbit 
(7074S) from Cell Signaling Technology; the rabbit polyclonal antibody against OGT 
(O0164), mAb against α-tubulin (T6199) and VSV (V5507) from Sigma; mAb against 
integrin β1 (610468) and paxillin (610052) from BD Biosciences; mAb against active 
integrin β1 (HUTS-4; 2079Z) and peroxidase-conjugated secondary antibodies against 
mouse (AP124P) and goat (AB324P) from Millipore; Alexa Fluor 488 conjugated anti-
mouse (A11029) from Invitrogen; TO-PRO-3 (T3605) from Molecular Probe; GFP-
agarose (MBL, D153-8) and goat antibody against GFP (Rockland, 600-101-215). The 
mAb against human β1 (P5D2) was obtained from Developmental Studies Hybridoma 
Bank, University of Iowa, USA. Human fibronectin (FN) and doxycycline hyclate 
(D9891) was from Sigma-Aldrich. An ABC kit was acquired from Vector Laboratories, 
and Ab-Capcher Mag was from ProteNova (Takamatsu, Japan). 
 
2.2 Cell culture and expression plasmids 
HeLa and 293T cell lines (RIKEN, Japan) were maintained at 37 °C in DMEM high 
glucose (Invitrogen) supplemented with 10% FBS under a humidified atmosphere that 
contained 5% CO2. To express GFP-tagged talin (28) and 2X VSV-tagged FAK, 
expression vector pEGFP-N1-talin-GFP (Addgene 26724) and pRKVSV-FAK were 
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kindly provided from Dr. Anna Huttenlocher (28) and Dr. Kenneth Yamada (29), 
respectively. The pcDNA3.1/myc-his expression vector containing human OGT was 
kindly provided by Dr. Yuanyuan Ruan (School of basic medical sciences, Fudan 
University, China). Transfection was performed using PEI MAX (molecular weight, 40 
kDa; Polysciences Inc., PA) and following the dictates of the U.S. patent document 
(US20110020927A1) with minor modifications. Briefly, 24 h prior to transfections cells 
were seeded on a 10 cm dish, and expression vectors with PEI MAX (1 mg/ml in 0.2 M 
hydrochloric acid) were preincubated for 15 min at a 1:3 ratio in 2,000 μl of a solution 
that contained 20 mM CH3COONa buffer, pH 4.0, and 150 mM NaCl. Cells and DNA 
complexes were further incubated for 24 h with 10 ml normal culture media to promote 
expression. 
 
2.3 Establishment of doxycycline-inducible OGT knockdown cells 
We used CS-RfA-ETBsd doxycycline (DOX)-dependent inducible RNA interference 
mediated by a single lentivirus vector (RIKEN) for the knockdown experiment (30). The 
following oligonucleotides were inserted into pENTR/H1/TO (sense, 
CACCGCTGAGCAGTATTCCGAGAAACTCGAGTTTCTCGGAATACTGCTCAGC
C, antisense, 
AAAAGGCTGAGCAGTATTCCGAGAAACTCGAGTTTCTCGGAATACTGCTCAG
C) with minor modification from a procedure established in a previous report (16). Using 
LR clonase, inserted oligo was then transferred to CS-RfA-ETBsd, which encodes 
tetracycline-dependent trans-activators for shRNA expression. To prepare the viruses, PEI 
MAX was used to transfect the resultant vector into 293T cells with packaging plasmids. 
HeLa and 293T cells were then infected by the obtained viruses and selected for stable 
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integration with 10 μg/ml of blasticidin. The shRNA-mediated silencing of OGT was 
induced by the addition of DOX in the established cell line, and the cells cultured by 
DOX-free medium were used as the control in the present study. 
 
2.4 Immunoprecipitation and Western Blot 
The cells were washed with PBS, and lysed in lysis buffer (20 mM Tris-HCl, pH 7.4, 150 
mM NaCl, 0.1% Triton X-100) with protease and phosphatase inhibitors (Nacalai Tesque, 
Japan). The supernatants were collected, and the protein concentrations were determined 
using a bicinchoninic acid (BCA) protein assay kit (Pierce, IL). Equal amounts of proteins 
were subjected to SDS-PAGE and then transferred to PVDF membranes. To detect active 
integrin β1, we prepared samples under non-reducing conditions. The membranes were 
blocked either with 5% nonfat milk in TBST or with 3% BSA for 2 h at room temperature, 
and then the proteins were probed with antibodies against O-GlcNAc, OGT, α-tubulin, 
active integrin β1 (HUTS-4) (31,32), integrin β1 (Millipore), paxillin, VSV, and GFP. 
After being washed, the membranes were incubated with horseradish peroxidase-
conjugated secondary antibodies. Detection was accomplished using an HRP substrate 
(Millipore) according to the manufacturer’s instructions. For immunoprecipitation, the 
supernatant (500 µg of protein) was incubated with an anti-VSV or an anti-paxillin with 
an Ab-Capcher Mag. GFP-talin was immunoprecipitated with GFP-conjugated beads. 
The immunoprecipitates were washed with lysis buffer and subjected to SDS-PAGE. The 
immunocomplexes then were detected using the indicated antibodies. A mAb against α-
tubulin was used as the loading control. 
 
2.5 Cell adhesion Assay 
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Cell adhesion assays were performed in a 96-well CellCarrier (PerkinElmer, Japan) 
coated with FN (5 µg/ml) overnight. HeLa cells were pre-treated with or without DOX 
(0.1µg/ml) for 24 hours. Cells were re-plated at a density of 104 cells/well in plates using 
serum-free DMEM with 0.1% BSA, followed by incubation at 37 °C for 20 min. Non-
adherent cells were removed by washing 3 times with PBS. Cells were fixed with 4% 
formaldehyde and stained DAPI (Invitrogen), and were then imaged by fluorescent 
microscopy using an Operetta CLS (PerkinElmer, Japan). To count the number of nuclei 
in the each well, images were analyzed using Harmony software (PerkinElmer). 
 
2.6 Immunofluorescence 
Cells were plated onto FN-coated glass coverslips (MatTek Corporation, Ashland, MA) 
for 1 h, washed with PBS, and fixed with 4% PFA. For permeabilization, the cells were 
treated with 0.1% Triton X-100 in PBS. The cells were blocked with 0.1% Tween 20 and 
3% BSA in PBS and then stained with paxillin, active β1 (HUTS-4), total β1 (P5D2), and 
OGT antibodies overnight at 4 °C. The samples were followed by incubation with anti-
mouse Alexa Fluor 488-conjugated secondary antibody, and were then incubated with 
TO-PRO-3. Images were acquired by sequential excitation using an Olympus FV1000 
laser scanning confocal microscope with an UPlanSApo 60X/1.35 Oil objective and high 
sensitivity Gallium arsenide phosphide detector units operated by F10-ASW ver. 4.02 
software. In order to count the number of FAs, we followed a protocol previously 
described using ImageJ (33), excluding focal adhesions that were less than 0.2 µm2, 
because these disappeared quickly (34). OGT-overexpressing cells were identified via co-
immunostaining with OGT. The relative fluorescence intensities of active integrin β1 and 
total integrin β1 were quantified using ImageJ software. 
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2.7 Video microscope 
Glass-bottom dishes (Asahi Glass, Shizuoka, Japan) were pre-coated with FN (10 µg/ml) 
in PBS, let stand at 4 °C overnight, and were then blocked with 1% BSA. Ten Thousand 
cells were suspended in 2 ml of DMEM containing 3% FBS medium, which was then 
added to each FN-coated glass-bottom dish and monitored for 12 h using AxioVision 
equipment (Carl Zeiss, Germany). Images were acquired using an inverted microscope 
(Axio Observer.D1; Carl Zeiss) every 10 min with 5% CO2 at 37 °C in a heated chamber 
equipped with temperature and CO2 controllers (Onpu-4 and CO2; AR BROWN, Tokyo, 
Japan) during time-lapse imaging. Cell motility was evaluated using an AxioVision 
Tracking module (Carl Zeiss). 
 
2.8 Chemoenzymatic labeling assay 
Chemoenzymatic labeling and biotinylation of proteins in cell lysates was carried out 
using the Click-iT O-GlcNAc Enzymatic Labeling System (Invitrogen). Briefly, the 
whole-cell lysate of 293T cells transfected with an expression plasmid for VSV-FAK or 
GFP-talin (500 µg), and HeLa cells was immunoprecipitated and then labeled with 
labeling enzyme GalT and UDP-GalNAz according to Click-iT O-GlcNAc Enzymatic 
Labeling System protocol (Invitrogen). Labeled proteins were conjugated with an alkyne-
biotin compound following the Click-iT Protein Analysis Detection Kit protocol 
(Invitrogen). Control experiments were performed in the absence of GalT and UDP-
GalNAz. Biotinylated and control samples were then subjected to SDS-PAGE and 
transferred to a PVDF membrane for further detection using an ABC kit (Vector 
Laboratories). 
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2.9 Statistics 
All results shown are the results of at least two independent experiments and are shown 
as representative data. The values represent the mean ± S.E.M. P-values were calculated 
using a Welch’s correction t-test using GraphPad Prism version 5. (* represents P-value 
< 0.05, ** represents P-value < 0.01).
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3. Results 
3.1 Established OGT knockdown (KD) cells 
A growing number of studies have shown that O-GlcNAcylation plays a critical role in 
the regulation of tumor cell growth (14) and cancer metastasis (35,36). To investigate the 
effects of O-GlcNAc expression on cell adhesion and migration, we used the DOX-
dependent inducible shRNA KD system to establish OGT KD HeLa cells. In this cellular 
system, OGT and O-GlcNAc were expressed at normal levels in the absence of DOX, 
whereas both expressions were drastically suppressed in the presence of DOX in the 
culture media at indicated concentrations, as shown in Fig. 1A. Furthermore, similar 
suppression levels were observed even following incubation at the lowest concentration 
of 0.1 μg/ml after 24 h (Fig. 1B), suggesting an effective KD of OGT and a rapid turnover 
of O-GlcNAc levels in HeLa cells. After culture for 48 hours, elongated cell shapes were 
converted to a more-rounded morphology, and the KD cells showed significantly 
increased cell spreading areas compared with those in the control cells (Fig. 1C). These 
observations suggest the impact that O-GlcNAcylation exerts on cell morphology.  
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Fig. 1 Knockdown of OGT suppressed O-GlcNAcylation and enhanced cell 
spreading in HeLa cells 
A,B, The expression levels of OGT and O-GlcNAcylation from cell lysates of doxycycline 
(DOX)-controlled OGT knockdown HeLa (KD) cells were verified with concentrations 
of DOX at 0, 0.1, 0.5, 1.0, and 5.0 μg/ml for 72 h (A); or at indicated time with 0.1 μg/ml 
DOX (B). The control (Ctrl) indicates the cells treated without DOX. Cell lysates from 
the indicated cells were subjected to WB with the O-GlcNAc (CTD110.6), OGT and α-
tubulin antibodies. C, Representative images of cell spreading were shown after 
incubation for 48 h. Cells were incubated with (KD) or without (Ctrl) 0.1 μg/ml DOX for 
24 or 48 h on a normal culture dish, after which the cell areas were measured. Values 
represent the mean ± S.E.M. (n=50). **P < 0.01 (Welch’s correction t-test). Scale bars, 
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15 μm. Experiments were independently repeated at least 2 times 
 
3.2 Knockdown of O-GlcNAcylation enhanced cell adhesion and FA formation and 
suppressed cell motility  
Next, we used a fibronectin (FN)-coated dish to investigate the effects of OGT KD on 
cell adhesion, FA formation, and cell motility. To verify the initial stage of cell adhesion, 
we performed a 20-min cell adhesion assay on FN. Interestingly, the number of adhered 
cells was drastically increased in the KD cells compared with that in the control cells (Fig. 
2A). During cell adhesion, integrins and cytoplasmic proteins such as paxillin, talin and 
FAK become clustered in the plane of the cell membrane and in well-developed 
aggregates, the so-called FA plaque, which can be detected by immunofluorescence 
microscopy (37). Consistent with their enhancement of cell adhesion, in the present study 
OGT KD cells also promoted an increase in FA formation, by comparison with the activity 
in control cells (Fig. 2B). By contrast, the KD cells showed a significant reduction in cell 
motility, as observed by video microscopy (Fig. 2C). These data indicate that a loss of O-
GlcNAcylation promotes cell adhesion and focal contact formation, while suppressing 
cell migration. 
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Fig. 2 Reduced O-GlcNAcylation promoted cell adhesion and FA formation, but 
decreased cell migration 
HeLa cells were cultured in the presence (KD) or absence (Ctrl) of DOX for 24 h. A; 
Twenty minutes after replating cells onto FN-coated 96-well plates, the attached cells 
were fixed, and then the nuclei were stained and counted. Representative fields were 
photographed via fluorescent microscopy. Scale bars, 30 μm. Values represent the mean 
± S.E.M. (n=11). ** P < 0.01 (Welch’s correction t-test). B, Cells were allowed to spread 
on FN-coated coverslips for 1 hour. Cells were then stained with anti-paxillin antibody 
(green) and TO-PRO-3 (blue). The numbers of focal adhesion were quantified by ImageJ 
software. Scale bars, 5 μm. Values represent the mean ± S.E.M. (n=11). **P < 0.01 
(Welch’s correction t-test). C; Cell motility was observed by time-lapse video microscopy. 
Values represent the mean ± S.E.M. (n=30). ** P < 0.01 (Welch’s correction t-test). 
Experiments were independently repeated at least 2 times. 
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3.3 Talin, FAK and paxillin were O-GlcNAc-modified proteins 
Previous studies have revealed that some forms of protein FA plaque such as paxillin and 
talin are modified by O-GlcNAc (24,25). In the present study we investigated whether O-
GlcNAc modification of those target proteins also occurred in HeLa cells in this system. 
Consistent with previous studies, O-GlcNAc modifications were detected on both paxillin 
and talin, while O-GlcNAcylation levels for both proteins were significantly decreased in 
KD cells, compared with that seen in control cells (Fig. 3A,B). The post-translational 
modifications of FAK might control the protein–protein-interaction adaptor functions in 
cell attachment (38). Importantly, we also found that FAK, a key molecule for integrin-
mediated signaling, was also a target protein for O-GlcNAcylation, which was decreased 
in the KD cells (Fig. 3C). The suppression of O-GlcNAcylation on FAK and talin was 
also confirmed in DOX-induced OGT KD 293T cells (data not shown). To further 
establish the occurrence of O-GlcNAcylation in these proteins, we conducted a 
chemoenzymatic labeling assay using an azido-N-acetylgalactosamine sugar, as described 
in Experimental procedures. Clearly, talin, FAK and paxillin were labeled, which proved 
they are O-GlcNAcylated proteins (Fig. 4 A-C). These results suggest that O-
GlcNAcylation may affect both integrin β1-mediated complex formation and FA 
formation, which confirms this process as a regulator of cell adhesion and migration. 
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Fig. 3 Decreased O-GlcNAcylation levels of paxillin, talin and FAK in OGT-KD cells.  
HeLa cells (A) or cells transfected with talin (B) or FAK (C) were incubated without 
(Ctrl) or with (KD) DOX. The cell extracts were immunoprecipitated with indicated 
antibodies, and western blotted with anti-O-GlcNAc or indicated antibodies, respectively. 
Experiments were independently repeated at least 3 times. 
 
 
 
 
Fig. 4 Confirmation of O-GlcNAcylation on talin, FAK and paxillin. 
Cell lysates of 293T cells transfected with talin (A), FAK (B) or wild-type HeLa cells (C) 
were immunoprecipitated with anti-GFP, anti-VSV or anti-paxillin antibodies, 
respectively, followed by click chemistry labeling of O-GlcNAc residues with (+) or 
without (-) GalT and UDP-GalNAz, and were detected using an ABC kit, as described in 
“Experimental procedures”. Experiments were independently repeated at least 2 times. 
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3.4 Reduction of O-GlcNAcylation promoted complex formation 
FAK is a key component of the signal transduction pathways triggered by integrins. When 
cells bind to the extracellular matrix (ECM), FAK is usually recruited to integrin-
mediated nascent FA, because it interacts directly through the cytoskeletal proteins talin 
and paxillin, with the cytoplasmic tail of integrin β1 (39). Therefore, we compared the 
ability of control and KD cells to form FA complexes. As shown in Fig. 5A, the complexes 
immunoprecipitated with anti-FAK antibody showed higher levels of paxillin in KD cells 
than in control cells. Consistently, KD cells demonstrated a greater number of complex 
formations composed of both β1 integrin and talin (Fig. 5B) and talin and FAK (Fig. 5C). 
A similar phenomenon was also confirmed in OGT-KD 293T cells (data not shown).  
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Fig. 5 Increased focal adhesion complex formation in OGT KD cells  
Cell lysates from the Ctrl and KD HeLa cells that were transfected with expression 
plasmids of FAK (A), talin (B) or both FAK and talin (C), were immunoprecipitated by 
indicated antibodies and then subjected to Western blotting as described in “Experimental 
procedures”. The relative ratios are shown at the bottom (n=3 individual experiments). 
Values represent the mean ± S.E.M. *P < 0.05 (Welch’s correction t-test). Cell lysates 
were used as input. Experiments were independently repeated at least 3 times. 
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3.5 Knockdown of O-GlcNAcylation activated integrin β1 
Given the increase in FA complex formation in KD cells, it is reasonable to speculate that 
OGT-KD may affect integrin activation. Integrin β1 whose conformation promotes ligand 
binding and appropriate affinity are said to be in active state. Integrin-mediated adhesion 
can recruit FA proteins to form FA plaque, and then trigger conformational activation, so-
called inside-out signaling, of integrin β1 in the ectodomain, which then can be 
recognized by a specific antibody (40,41) that we used to examine the expression levels 
of active integrin β1 in both control and KD cells. The expression levels of active β1 in 
immunostaining (Fig. 6A) or cell lysates (Fig. 6B) were clearly upregulated in the KD 
cells compared with control cells. In contrast to KD cells, the expression levels of active 
β1 were suppressed in the OGT-overexpressing HeLa cells, which further suggested that 
O-GlcNAcylation negatively regulates integrin-mediated inside-out signaling. Thus, we 
were convinced that OGT could be a novel regulator for FA complex formation and 
integrin activation by dynamically regulating cell adhesion and migration.  
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Fig. 6 Comparison of the expression levels of active integrin β1 among the Ctrl, KD 
and OGT-overexpressing cells  
A; A representative immunostaining pattern with anti-active β1 or anti-β1 antibodies in 
the Ctrl, KD, and OGT-overexpressing (OGT) HeLa cells. Cells were cultured on FN-
coated coverslips for 1 h and then subjected to immunostaining analyses. The relative 
fluorescence intensities of KD and OGT-overexpressing cells were compared with the 
control, and relative fluorescence intensity was 1.0 for the control cells. Scale bar, 5 μm. 
B, The expression levels of active and total integrin β1 were verified by immunoblotting 
with the indicated antibodies in Ctrl and KD HeLa cells, or parent (WT) or transiently 
OGT-overexpressing (OGT) HeLa cells. The relative ratios are shown at the bottom (n=10 
random fields of view). Values represent the mean ± S.E.M. *P < 0.05 (Welch’s correction 
t-test), n.s, not significant (P > 0.05), experiments were independently repeated at least 2 
times. 
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4. Discussion 
In the present study, we clearly showed that O-GlcNAcylation negatively regulates 
integrin-mediated cell adhesion and FA complex formation as well as integrin activation, 
which results in the control of cell migration on the ECM (Fig.7). Our findings are the 
first to demonstrate that OGT may function as a key regulator of FA complex formation 
during cell-ECM adhesion. These results provide clues to understanding the roles of O-
GlcNAcylation in cell migration. 
Fig. 7 Proposed molecular mechanism for the regulation of cell adhesion and 
migration by O-GlcNAcylation 
 
Cell migration is a central process in the development and maintenance of multicellular 
organisms (19). Although the detailed mechanisms underlying cell migration remain 
unclear, it is reasonable to postulate that integrin-mediated cell adhesion could regulate 
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migration, which would allow communication between cell-ECM contact and the actin 
cytoskeleton through focal adhesions (42). The dynamic balance between adhesion 
receptors and the binding of ECM ligands provides FA turnover that regulates adhesion 
formation and disassembly (43). In the framework of this model, an imbalance in the 
processes of attachment and detachment leads to conformational changes that mediate 
abnormal adhesion (22). In the present study, we clearly demonstrated that the 
suppression of O-GlcNAcylation inhibited HeLa cell migration while it enhanced cell-
ECM adhesion (Fig. 2), which indicated that O-GlcNAcylation is involved in the 
regulation of integrin-mediated cell adhesion. Consistently, FAK serves as a key regulator 
of FA assembly and disassembly processes that are fundamental for efficient cell 
migration (44). Indeed, there were more stress fibers and focal adhesions in FAK-
deficient cells, while cell motility was inhibited (45). Aberrant cell-ECM adhesiveness is 
likely to suppress cell migration, and proper cell adhesion is an important determinant for 
cell migration (46). Thus, our data are reasonable in that the knockdown of O-
GlcNAcylation aberrantly increased cell adhesion, as well as spreading and FA complex 
formation, which in turn decreased cell migration.  
We were intrigued as to why a knockdown of OGT would enhance integrin activation. 
Integrins are the major cell surface receptors used to assemble and recognize a functional 
ECM, and to facilitate cell signaling and migration (47). The organization of cell 
adhesions is complex, and includes a number of cytoplasmic proteins such as paxillin, 
talin, FAK, vinculin, and α-actinin (40). Integrin activation is associated with an array of 
biological and pathological conditions involving both outside-in and inside-out signaling 
(48). Accumulating data have indicated that the cytoplasmic domain of the integrin β1 
subunit cooperatively promotes integrin activation through the binding of talin (49). 
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Consequently, our results clearly showed the interaction of integrin β1 with talin, and the 
association of FAK, paxillin and/or talin both were greatly increased in the KD cells, 
which suggests that the KD of OGT promotes inside-out signaling (Fig. 5). A reciprocal 
relationship between O-GlcNAcylation and O-phosphorylation has been observed in the 
specific serine or threonine residue of particular proteins (50,51), Consistently, a loss of 
paxillin phosphorylation at Ser-250 markedly inhibits focal adhesion turnover and cell 
migration (52). Therefore, how O-GlcNAcylation affects the O-phosphorylation of FA 
complex proteins is worthy of clarification. 
The O-GlcNAcylation of FAK is noteworthy. Integrins do not possess enzymatic activity; 
rather, they associate with a number of cytoplasmic protein kinases such as FAK and Src. 
Tyrosine-phosphorylated FAK is well known to be a promoter of interactions with various 
Src-homology 2- and 3-containing proteins, and to initiate enzymatic cascades via these 
associated kinases that ultimately leads to changes in cell behavior (53). By contrast, 
serine- or threonine-phosphorylation on FAK is not well understood. FAK 
phosphorylation at either Ser-732 or Ser-722 has recently been recognized as important 
for microtubule organization, nuclear movement, and neuronal migration during cell 
adhesion (54,55). Interestingly, phosphorylation of both Ser-843 and Ser-910 on FAK 
exhibited synchronized phosphorylation during cell mitosis (56), which may be related to 
O-GlcNAcylation since expression levels of OGT change during mitosis (57). 
Furthermore, a cluster of serine phosphorylation sites was recently identified at the 
initiation of the FA targeting domain in FAK (58), which may suggest some of those sites 
could be modified by O-GlcNAcylation. Thus, to elucidate the roles of OGT in cell 
biology, it is necessary to identify the specific sites and functions of O-GlcNAcylation in 
FAK.  
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Our results indicate that O-GlcNAcylation plays important roles in regulating cell 
adhesion, FA complex formation, and cell migration. Emerging data has already 
established that O-GlcNAc modification has a critical role in the progress of human 
diseases, and particularly diseases such as cancer, diabetes and Alzheimer’s (10). 
Intriguingly, FAK has been associated with insulin resistance in adipocytes in the early 
stages of type II diabetes (59,60), and has also been implicated in the deposition of β-
amyloid plaque (61,62). It would be reasonable to assume that dynamic regulation of FAK 
O-GlcNAcylation with phosphorylation may partially serve as a possible explanation for 
a number of diseases.  
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Abbreviations  
OGT: O-GlcNAc transferase;  
KD: knockdown;  
DOX: doxycycline;  
shRNA: short hairpin RNA;  
FAK: focal adhesion kinase;  
FA: focal adhesion;  
AD: Alzheimer’s disease;  
ECM: Extracellular matrix;  
VSV: Vesicular Stomatitis Virus glycoprotein. 
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